304
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Transdermal Delivery of Tadalafil. I. Effect of Vehicles on Skin Permeation

, &
Pages 329-336 | Published online: 01 Mar 2009

References

  • B. J. Aungst, J. A. Blake, M. A. Hussain. 1990. Contributions of drug solublization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res. 7:712–718.
  • A. K. Banga, S. Bose, T. K. Ghosh. 1999. Iontophoresis and electroporation: Comparisons and contrasts. Int. J. Pharm. 179:1–19.
  • B. W. Barry. 1983. Dermatological formulation: Percutaneous absorption. New York and Basel: Marcel Dekker.
  • B. W. Barry. 1987. Mode of action of penetration enhancers in human skin. J. Control Rel. 6:85–97.
  • D. Bommannan, R. O. Potts, R. H. Guy. 1991. Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J. Control Rel. 16:299–304.
  • J. Buvat, H. Van Ahlen, H. Schmitt, H. Chan, C. Kuepfer, L. Varanese. 2006. Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries. J. Sex. Med. 3 (3):512–520.
  • D. Chantasart, S. K. Li, N. He, K. S. Warner, S. Prakongpan, W. Higuchi. 2004. Mechanistic studies of branched-chain alkanols as skin permeation enhancers. J. Pharm. Sci. 93:762–779.
  • C. L. Cheng, C. H. Chou. 2005. Determination of tadalafil in small volumes of plasma by high performance liquid chromatography with UV detection. J. Chromatogr. B 822:278–284.
  • M. Corbo, J. C. Liu, Y. W. Chien. 1990. Bioavailability of propranolol following oral and transdermal administration in rabbits. J. Pharm. Sci. 79:584–587.
  • P. Costa, J. Buvat, S. Holmes, S. Weitckus, H. Petto, K. Hamidi, L. Varanese. 2006. Predictors of tadalafil efficacy in study comparing two dosing regimen. J. Sex. Med. 3 (6):1050–1058.
  • G. M. El Maghraby. 2008. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: Effects of cosurfactants. Int. J. Pharm. 355:285–292.
  • G. M. El Maghraby, A. C. Williams, B. W. Barry. 1999. Skin delivery of oestradiol from deformable and traditional liposomes: Mechanistic studies. J. Pharm. Pharmacol. 51:1123–1134.
  • G. M. El Maghraby, A. C. Williams, B. W. Barry. 2000. Oestradiol skin delivery from ultradeformable liposomes: Refinement of surfactant concentration. Int. J. Pharm. 196:63–74.
  • G. M. El Maghraby, A. C. Williams, B. W. Barry. 2006. Can drug bearing liposomes penetrate intact skin?. J. Pharm Pharmacol. 58:415–429.
  • G. M. Golden, J. E. McKie, R. O. Potts. 1987. Role of stratum corneum lipid fluidity in transdermal drug flux. J. Pharm. Sci. 76:25–28.
  • S. R. Gorukanti, L. Li, K. H. Kim. 1999. Transdermal delivery of antiparkinsonian agent, benzotropine. I. Effect of vehicles on skin permeation. Int. J. Pharm. 192:159–172.
  • G. M. El Maghraby, M. A. Hedaya, D. R. El-Afify. 2006. The effect of ciprofloxacin and clarithromycin on sildenafil oral bioavailability in human volunteers. Biopharm. Drug Dispos. 27:103–110.
  • T. Higuchi. 1960. Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem. 11:85–97.
  • T. Holas, K. Vávrová, M. Sima, J. Klimentová, A. Hrabálek. 2006. Synthesis and transdermal permeation-enhancing activity of carbonate and carbamate analogs of transkarbam 12. Bioorg. Med. Chem. 14:7671–7680.
  • A. Hrabálek, K. Vávrová, P. Dolezal, M. Machácek. 2005. Esters of 6-aminohexanoic acid as skin permeation enhancers: The effect of branching in the alkanol moiety. J. Pharm. Sci. 94:1494–1499.
  • A. Jetter, M. Kinzig-Schippers, M. Walchner-Bonjean, U. Hering, J. Bulitta, P. Schreiner, F. Sorgel, U. Fuhr. 2002. Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin. Pharmacol. Ther. 71:21–29.
  • L. Kikwai, N. Kanikkannan, R. J. Babu, M. Singh. 2002. Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro. J. Control Rel. 83:307–311.
  • K. Knutson, S. L. Krill, J. Zhang. 1990. Solvent mediated alteration of the stratum corneum. J. Control Rel. 11:93–103.
  • J. Kost, U. Pliquett, S. Mitragotri, A. Yamamoto, R. Langer, J. Weaver. 1996. Synergistic effect of electric field and ultrasound on transdermal transport. Pharm. Res. 13:633–638.
  • Y. S. R. Krishnaiah, V. Satyanarayana, R. S. Karthikeyan. 2002. Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J. Pharm. Pharm. Sci. 5:124–130.
  • M. L. Leichtnam, H. Roland, P. Wuthrich, R. H. Guy. 2006. Enhancement of transdermal testosterone delivery by supersaturation. J. Pharm. Sci. 95:2373–2379.
  • M. Mezei, V. Gulasekharam. 1980. Liposomes—a selective drug delivery system for topical route of administration. 1. Lotion dosage form. Life Sci. 26:1473–1477.
  • L. L. Miller, C. J. Kolaskie, G. A. Smith, J. Rivier. 1990. Transdermal iontophoresis of gonadotropin releasing hormone and two analogues. J. Pharm. Sci. 79:490–493.
  • B. Mollgaard, A. Hoelgaard. 1983. Vehicle effect on topical drug delivery. I. Influence of glycol and drug concentration on skin transport. Acta Pharm. Suec. 20:433–442.
  • G. J. Muirhead, S. Faulken, J. A. Harness, J. Taubel. 2002. The effect of steady state erythromycin and azithromycin onpharmacokinetics of sildenafil in healthy volunteers. Br. J. Clin. Pharmacol. 53:37S–43S.
  • G. J. Muirhead, M. B. Wulff, A. Fielding, D. Kleinermans, N. Buss. 2000. Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir. Br. J. Clin. Pharmacol. 50:99–107.
  • R. Panchagnula, H. Desu, A. Jain, S. Khandavilli. 2005. Feasibility studies of dermal delivery of paclitaxil with binary combinations of ethanol and isopropyl myristate: Role of solubility, partitioning and lipid bilayer perturbation. Il Farmaco 60:894–899.
  • R. Panchagnula, P. S. Salve, N. S. Thomas, A. K. Jain, P. Ramarao. 2001. Transdermal delivery of naloxone: Effect of water, propylene glycol, ethanol and their combinations on the permeation through rat skin. Int. J. Pharm. 219:95–105.
  • H. Porst, H. Padma-Nathan, F. Giuliano, G. Anglin, L. Varanese, R. Rosen. 2003. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial. Urology 62 (1):121–125.
  • Y. S. Rhee, J. Y. Huh, C. W. Park, T. Y. Nam, K. R. Yoon, S. C. Chi, E. S. Park. 2007. Effects of vehicles and enhancers on transdermal delivery of clebopride. Arch. Pharm. Res. 30:1155–1161.
  • B. J. Ring, B. E. Patterson, M. I. Mitchel, J. Gillespie, A. W. Bedding, H. Jewell, C. D. Payne, S. T. Forgue, J. Eckstein, S. A. Wrighton, D. L. Phillips. 2005. Effect of tadalafil on cytochrome P450 3A4-mediated clearance: Studies in vitro and in vivo. Clin. Pharmacol. Ther. 77 (1):63–75.
  • H. Schreier, J. Bouwstra. 1994. Liposomes and niosomes as topical drug carriers: Dermal and transdermal drug delivery. J. Control Rel. 30:1–15.
  • R. Shabsigh, A. D. Seftel, R. C. Rosen, H. Porst, S. Ahuja, M. C. Deeley, C. S. Garcia, F. Giuliano. 2006. Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction. Urology 68:689–696.
  • D. O. Sussman. 2004. Pharmacokinetics, pharmacodynamics and efficacy of phosphodiesterase type 5 inhibitors. J. Am. Osteopath. Assoc. 104 (3):S11–S15.
  • K. Takahashi, S. Tamagawa, T. Katagi, H. Yoshitomi, A. Kamada, J. H. Rytting, T. Nishihata, N. Mizuno. 1991. In vitro transport of sodium diclofenac across rat abdominal skin: Effect of selection of oleaginous component and the addition of alcohols to the vehicle. Chem. Pharm. Bull. 39:154–158.
  • N. S. Thomas, R. Panchagnula. 2003. Transdermal delivery of zidovudine: Effect of vehicles on permeation across rat skin and their mechanism of action. Eur. J. Pharm. Sci. 18:71–79.
  • E. Touitou, N. Dayan, L. Bergelson, B. Godin, M. Eliaz. 2000. Ethosomes—novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J. Control Rel. 65:403–418.
  • J. N. Twist, J. L. Zatz. 1988. Membrane–solvent–solute interaction in a model permeation system. J. Pharm. Sci. 77:536–540.
  • K. Vávrová, J. Zbytovská, A. Hrabálek. 2005. Amphiphilic transdermal permeation enhancers: Structure–activity relationship. Curr. Med. Chem. 12 (19):2273–2291.
  • A. C. Williams, B. W. Barry. 2004. Penetration enhancers. Adv. Drug Del. Rev. 56:603–618.
  • K. Wilner, L. Laboy, M. LeBel. 2002. The effects of cimetidine and antacid on the pharmacokinetic profile of sildenafil citrate in healthy male volunteers. Br. J. Clin. Pharmacol. 53:31S–36S.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.